15 results
424B3
SLGL
Sol-Gel Technologies Ltd
4 Apr 24
Prospectus supplement
9:05am
Society, approximately 16 million people in the United States are affected by rosacea. Subtype II rosacea is characterized by small, dome-shaped
POS AM
SLGL
Sol-Gel Technologies Ltd
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
. National Rosacea Society, approximately 16 million people in the United States are affected by rosacea. Subtype II rosacea is characterized by small
20-F/A
2021 FY
SLGL
Sol-Gel Technologies Ltd
7 Apr 22
Annual report (foreign) (amended)
4:06pm
redness, inflammatory lesions, burning and stinging. According to the U.S. National Rosacea Society, approximately 16 million people in the United States
6-K
EX-99.1
ceq3ycz8ntlx96 255
27 Jul 21
TWYNEO®, a once-daily cream treatment for acne vulgaris, is the first FDA‑approved fixed‑dose combination of tretinoin and benzoyl peroxide
10:39am
6-K
EX-99.1
lbswnh7bosnm83 sc
8 Jan 20
Sol-Gel Hosts Investor Call to Discuss Positive Results from Twyneo® Phase 3 Program in Acne Vulgaris
6:02am
6-K
EX-99.2
ku0vc
8 Jan 20
Sol-Gel Hosts Investor Call to Discuss Positive Results from Twyneo® Phase 3 Program in Acne Vulgaris
6:02am
6-K
EX-99.1
kp9chs8lkj16nxsw70
30 Dec 19
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of
7:40am
6-K
EX-99.2
4cvsj mn59o
25 Jul 19
Current report (foreign)
6:02am
6-K
EX-99.1
gxetd3y
23 Jul 19
Current report (foreign)
8:19am
20-F
zki6m6vra9r myx4yk
26 Mar 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next